{"disease":{"id":"human-influenza","name":"human influenza"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07161739","title":"Vaccination Nudges From Pharmacists","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":20000,"lead_sponsor_name":"University of Calgary","has_results":false},{"nct_id":"NCT06207929","title":"Wearable Assisted Viral Evidence (WAVE) Study A Decentralized, Prospective Study Exploring the Relationship Between Passively-collected Data From Wearable Activity Devices and Respiratory Viral Infections","phase":"","overall_status":"COMPLETED","enrollment_count":18157,"lead_sponsor_name":"Evidation Health","has_results":false},{"nct_id":"NCT06800950","title":"Phase III Clinical Trial of Quadrivalent Influenza Virus Split Vaccine","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":4400,"lead_sponsor_name":"Institute of Medical Biology, Chinese Academy of Medical Sciences","has_results":false},{"nct_id":"NCT04160975","title":"Persuasion in Medicine: Experimental Evidence on Sender and Signal Effects","phase":"NA","overall_status":"COMPLETED","enrollment_count":3245,"lead_sponsor_name":"Harvard University","has_results":true},{"nct_id":"NCT03572491","title":"Preventive Effectiveness, Safety and Immunogenicity of a Allantoic Split Inactivated Seasonal Influenza Vaccine","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":2000,"lead_sponsor_name":"Research Institute for Biological Safety Problems","has_results":false},{"nct_id":"NCT05739474","title":"Tolerability, Safety and Immunogenicity Trial of the Flu-M Tetra Vaccine in Children","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":948,"lead_sponsor_name":"St. Petersburg Research Institute of Vaccines and Sera","has_results":false},{"nct_id":"NCT06385821","title":"A Study to Prove Non-inferior Immunogenicity of Grippol Quadrivalent Compared to Grippol Plus","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":824,"lead_sponsor_name":"NPO Petrovax","has_results":false},{"nct_id":"NCT05869201","title":"Tolerability, Safety and Immunogenicity Trial of the Flu-M Quadro, Tetravalent Inactivated Split Influenza Vaccine","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":450,"lead_sponsor_name":"St. Petersburg Research Institute of Vaccines and Sera","has_results":false},{"nct_id":"NCT04487041","title":"Tfh Dysfunction in HIV and Aging","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":400,"lead_sponsor_name":"University of Miami","has_results":false},{"nct_id":"NCT05422326","title":"A Study to Evaluate Safety and Immunogenicity of One or Two Booster Vaccinations With H5N6 Influenza Vaccine in Adults Primed With H5N1 Influenza Vaccine or Unprimed","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":260,"lead_sponsor_name":"Seqirus","has_results":false},{"nct_id":"NCT06984094","title":"First-in-human Safety and Immunogenicity Study of SCB-1022 and SCB-1033 in Healthy Older Adults","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":192,"lead_sponsor_name":"Clover Biopharmaceuticals AUS Pty","has_results":false},{"nct_id":"NCT06622590","title":"Phase I Clinical Trial of Quadrivalent Influenza Virus Split Vaccine","phase":"PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":180,"lead_sponsor_name":"Institute of Medical Biology, Chinese Academy of Medical Sciences","has_results":false},{"nct_id":"NCT03392389","title":"Safety, Reactogenicity, and Immunogenicity of mRNA-1653 in Healthy Adults","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":124,"lead_sponsor_name":"ModernaTX, Inc.","has_results":false},{"nct_id":"NCT04682444","title":"Efficacy and Safety of Enisamium Iodide for the Treatment of Acute Respiratory Viral Infections, Including Influenza.","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"Joint Stock Company \"Farmak\"","has_results":true},{"nct_id":"NCT04144348","title":"Safety and Immunogenicity of mRNA-1653, a Combined Human Metapneumovirus (hMPV) and Parainfluenza Virus Type 3 (PIV3) Vaccine, in Healthy Adults, and Children 12 to 59 Months of Age With Serologic Evidence of Prior Exposure","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":51,"lead_sponsor_name":"ModernaTX, Inc.","has_results":false},{"nct_id":"NCT03448705","title":"Safety of 4Fluart ID Suspension for Injection in Adult Subjects","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":36,"lead_sponsor_name":"Fluart Innovative Vaccine Ltd, Hungary","has_results":false},{"nct_id":"NCT03394209","title":"A Pharmacokinetics Study of Favipiravir in Patients With Severe Influenza","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":34,"lead_sponsor_name":"Capital Medical University","has_results":false},{"nct_id":"NCT05155319","title":"Universal Influenza A Vaccine in Healthy Adults","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":27,"lead_sponsor_name":"Emergent BioSolutions","has_results":false},{"nct_id":"NCT06546423","title":"Study of the Infectivity, Safety and Immunogenicity of Two Recombinant, Live-Attenuated, B/HPIV3 Vectored Vaccines Expressing the Fusion Glycoprotein of HMPV Delivered by Nasal Spray to HPIV3-Seropositive Children 24 to <60 Months of Age","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":24,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT04933968","title":"Study of ALVR106 in Patients With Respiratory Viral Infections After Hematopoietic Cell and Solid Organ Transplant","phase":"PHASE1, PHASE2","overall_status":"TERMINATED","enrollment_count":17,"lead_sponsor_name":"AlloVir","has_results":true},{"nct_id":"NCT03743688","title":"Kinetics of the Immune Response to Inactivated Influenza Vaccine in Healthy Adults","phase":"","overall_status":"COMPLETED","enrollment_count":10,"lead_sponsor_name":"Vanderbilt University Medical Center","has_results":false},{"nct_id":"NCT04431050","title":"Evaluation of a Single Use Point of Care Device for the Diagnosis of Respiratory Pathogens","phase":"","overall_status":"TERMINATED","enrollment_count":6,"lead_sponsor_name":"Imperial College London","has_results":true}],"total":22},"guidelines":[],"source":"Drug Landscape verified database"}